Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.
Sniderman
A D
AD
Laboratory for Cardiovascular Research, McGill University Health Centre, Royal Victoria Hospital, 687 Pine Ave. W, Montreal QC H3A 1A1. allan.sniderman@muhc.mcgill.ca
Bergeron
J
J
Frohlich
J
J
D001055:Apolipoproteins B / Q000097:blood*; D015415:Biomarkers; D008078:Cholesterol, LDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D016903:Drug Monitoring; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000503:physiopathology; D008148:Lovastatin / Q000494:pharmacology / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D011237:Predictive Value of Tests
D001055:Apolipoproteins B; D015415:Biomarkers; D008078:Cholesterol, LDL; D008148:Lovastatin